MétaCan
Menu
← Back to cohort

Do all patients with primary retroperitoneal sarcoma benefit from resection?

2025· article· en· W4410795467 on OpenAlexaff
Carol J. Swallow, Sara Iadecola, Juliana Restrepo-Lopez, Deanna Ng, Francesco Barretta, Silva Ljevar, Costanza Figura, Wendy Johnston, Marco Fiore, Carlo Morosi, Elena DiBlasi, Roberta Sanfilippo, Chiara Fabbroni, Silvia Stacchiotti, Rosalba Miceli, Rebecca A. Gladdy, Savtaj S. Brar, Dario Callegaro, Sandro Pasquali, Alessandro Gronchi

Bibliographic record

VenueJournal of Clinical Oncology · 2025
Typearticle
Languageen
FieldMedicine
TopicSarcoma Diagnosis and Treatment
Canadian institutionsUniversity of TorontoPrincess Margaret Cancer CentreMount Sinai Hospital
Fundersnot available
KeywordsMedicineSarcomaResectionSurgical resectionSurgeryRadiologyPathology

Abstract

fetched live from OpenAlex

e23549 Background: We aimed to determine the impact of early recurrence on the prognosis of patients who have undergone resection of primary retroperitoneal sarcoma (RPS) and to discover which preoperative patient/tumor features predict early recurrence. Methods: Consecutive patients with primary non-metastatic RPS who were managed at two high volume RPS referral centers between 03/2012 and 10/2019 were identified from prospectively maintained institutional databases. The primary study endpoint was Overall Survival (OS), defined as the time from diagnosis to death from any cause, estimated by the KM method. Patients were grouped by Disease-Free Interval following resection (DFI = 0-6, 7-12, 13-18, 19-24, > 24 mos). Univariate and multivariable analyses (UVA, MVA) were performed. The Sarculator risk calculator and the Inflammatory Biomarkers Prognostic Index (IBPI) were assessed as potential predictors of early recurrence, defined as DFI 0-6 mos. Results: 651 patients (median age = 62.7yrs, IQR = 51.9-71.3; F:M = 301:350) met inclusion criteria and form the study cohort. Median follow-up time was 75.9 mos (IQR 58.6-99.5). 566 of the 651 (87%) patients underwent resection of their primary RPS, while 85 (13%) did not, most commonly due to suboptimal PS. Of the 566 patients who underwent resection, 259 (46%) had developed a recurrence by the time of last follow-up, while 307 patients (54%) had not recurred. In the 259 patients whose tumor recurred, 49 (19%) recurred within 6 mos of primary RPS resection, 42 (16%) between 7 and 12 mos, 35 (14%) between 13 and 18 mos, 31 (12%) between 19 and 24 mos, and 102 (39%) after 24 mos. Patients who developed recurrence within 6 mos of resection had similar OS from the time of diagnosis to the 85 patients who did not have a resection (1-year estimates: 77.3% [95% CI: 66.4-90.1] vs 65.7% [56.1-76.8], respectively; 2-year estimates: 51.6% [39.1-68.0] vs 42.7% [33.1-55.1], p = 0.32), while patients who relapsed more than 6 mos after resection had longer OS than either of these groups (p < 0.001). Upon MVA, the HR for death in patients who recurred within 6 mos vs. that of patients who were not resected was 0.96 (95% CI: 0.60-1.53). No standard clinico-pathologic variable available preoperatively could be identified that predicted recurrence within 6 mos of primary resection. Neither composite score (Sarculator, IBPI) was able to reliably predict recurrence within 6 mos. Conclusions: DFI from primary RPS resection to first recurrence was less than 6 mos in ≈20% of patients. DFI directly correlated with OS from time of diagnosis. Patients who recurred within 6 mos of resection had an equivalent OS to patients who didn’t undergo resection, raising the question of whether resection was of any benefit. Current efforts focus on discovery of genomic characteristics that reflect adverse biology/host response and are discoverable preoperatively, in order to improve patient selection for surgery and for neoadjuvant therapy.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.010

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.068
GPT teacher head0.424
Teacher spread0.356 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical Oncology→Same topicSarcoma Diagnosis and Treatment→French-language works237,207→